Theraclion Stock OTC Markets
Stocks
TCLIF
FR0010120402
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
02:47:35 2026-04-08 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.5320 USD | +66.25% |
|
-.--% | +66.25% |
| Sep. 16 | Theraclion SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Sep. 16 | Theraclion widens its operating loss in the first half |  |
| Market Cap | 50.74M 57.62M 48.07M 43.4M 81.8M 5.52B 82.85M 575M 221M 2.82B 216M 212M 9.05B | P/E 2024 |
-2.66x | P/E 2025 | -6.33x |
|---|---|---|---|---|---|
| Enterprise Value | 58.59M 66.53M 55.51M 50.11M 94.45M 6.38B 95.67M 664M 256M 3.26B 250M 244M 10.46B | EV / Sales 2024 |
22.5x | EV / Sales 2025 | 55.4x |
| Free-Float |
32.52% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +66.25% | ||
| 6 months | +66.25% | ||
| Current year | +66.25% |
| Current year | 0.53 |  | 0.53 |
| 1 year | 0.53 | | 0.53 |
| 3 years | 0 | | 0.53 |
| 5 years | 0 | | 0.59 |
| 10 years | 0 | | 2.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Martin Deterre
CEO | Chief Executive Officer | - | 2023-05-23 |
Julie Veisseire
DFI | Director of Finance/CFO | - | - |
Alexandra Rocher
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Mehdi El Glaoui
BRD | Director/Board Member | - | 2021-06-21 |
Cédric Bellanger
BRD | Director/Board Member | - | 2022-01-27 |
Lijuan Deng
BRD | Director/Board Member | - | 2023-06-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +66.25% | -.--% | - | - | 57.62M | |
| -0.67% | +1.47% | +39.18% | +33.36% | 250B | |
| -2.02% | -0.00% | +11.75% | -10.70% | 156B | |
| -1.35% | +2.09% | -9.08% | +39.12% | 144B | |
| -0.52% | -2.17% | -55.29% | -17.33% | 63.26B | |
| -2.00% | -0.58% | +10.99% | +24.60% | 49.75B | |
| -1.55% | +4.23% | +34.25% | +54.10% | 48.58B | |
| -0.09% | +1.93% | -18.08% | -21.09% | 47.99B | |
| +2.47% | +5.43% | -4.18% | +40.30% | 46.22B | |
| -0.87% | +4.47% | +46.56% | +60.24% | 43.17B | |
| Average | +6.34% | +2.27% | +6.23% | +22.51% | 94.22B | |
| Weighted average by Cap. | -0.19% | +2.37% | +11.75% | +21.80% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 830K 943K 787K 710K 1.34M 90.4M 1.36M 9.41M 3.62M 46.21M 3.54M 3.46M 148M | 652K 740K 618K 558K 1.05M 70.99M 1.06M 7.39M 2.84M 36.29M 2.78M 2.72M 116M |
| Net income | -5.76M -6.54M -5.45M -4.92M -9.28M -627M -9.4M -65.26M -25.11M -320M -24.55M -24.01M -1.03B | -5.69M -6.46M -5.39M -4.87M -9.17M -620M -9.29M -64.5M -24.82M -317M -24.26M -23.73M -1.02B |
| Net Debt | 3.41M 3.87M 3.23M 2.92M 5.5M 371M 5.57M 38.66M 14.88M 190M 14.54M 14.23M 609M | 7.85M 8.92M 7.44M 6.72M 12.66M 855M 12.82M 89.01M 34.25M 437M 33.48M 32.75M 1.4B |
Employees
36
Calendar
Oct. 14
Earnings release - Q2 2026
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALTHE Stock
- TCLIF Stock
Select your edition
All financial news and data tailored to specific country editions
